The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his personal conduct," a government spokesperson said.
For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...
Nandita Vijayasimha, Bengaluru Monday, October 27, 2025, 08:00 Hrs [IST] ...
Our duration positioning, which was slightly longer than the index’s, boosted performance compared with the benchmark. Read ...
What Amazon learned when it automated the creation of product pages. by Stefan Thomke, Philipp Eisenhauer and Puneet Sahni For all the enthusiasm around generative AI, there’s a hurdle that is ...
Under the new regulation, pharmaceutical companies must obtain a Certificate of Analysis before selling any cough syrup in ...
Tampa Free Press on MSN
Drowning The Digital Threat: EPA Unveils New Cyber Playbook To Protect America’s Water
The U.S. Environmental Protection Agency (EPA) announced this week the release of new and updated planning tools designed to ...
All pharma-grade solvent manufacturers are required to obtain manufacturing licences through the ONDLS portal and upload real ...
Neuropsychiatric symptoms (NPSs) include but are not limited to psychotic and affective symptoms, agitation, disinhibition, ...
The latest incident reignited scrutiny of the world’s largest supplier of cheap, non-patented drugs. Read more at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback